Literature DB >> 28438952

Recommendations on hepatitis C screening for adults.

Roland Grad1, Brett Thombs2, Marcello Tonelli3, Maria Bacchus3, Richard Birtwhistle4, Scott Klarenbach5, Harminder Singh6, Veronique Dorais7, Nathalie Holmes7, Wendy Martin7, Rachel Rodin7, Alejandra Jaramillo Garcia7.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28438952      PMCID： PMC5403642          DOI： 10.1503/cmaj.161521

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  67 in total

1.  Disparity in market prices for hepatitis C virus direct-acting drugs.

Authors:  Isabelle Andrieux-Meyer; Jennifer Cohn; Evaldo S Affonso de Araújo; Saeed S Hamid
Journal:  Lancet Glob Health       Date:  2015-11       Impact factor: 26.763

2.  Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy.

Authors:  V Guadagnino; T Stroffolini; M Rapicetta; A Costantino; L A Kondili; F Menniti-Ippolito; B Caroleo; C Costa; G Griffo; L Loiacono; V Pisani; A Focà; M Piazza
Journal:  Hepatology       Date:  1997-10       Impact factor: 17.425

3.  A Canadian screening program for hepatitis C: is now the time?

Authors:  Hemant A Shah; Jenny Heathcote; Jordan J Feld
Journal:  CMAJ       Date:  2013-09-30       Impact factor: 8.262

4.  Comparison of a newly developed automated and quantitative hepatitis C virus (HCV) core antigen test with the HCV RNA assay for clinical usefulness in confirming anti-HCV results.

Authors:  Recep Kesli; Hakki Polat; Yuksel Terzi; Muhammet Guzel Kurtoglu; Yavuz Uyar
Journal:  J Clin Microbiol       Date:  2011-09-21       Impact factor: 5.948

5.  Sofosbuvir for previously untreated chronic hepatitis C infection.

Authors:  Eric Lawitz; Alessandra Mangia; David Wyles; Maribel Rodriguez-Torres; Tarek Hassanein; Stuart C Gordon; Michael Schultz; Mitchell N Davis; Zeid Kayali; K Rajender Reddy; Ira M Jacobson; Kris V Kowdley; Lisa Nyberg; G Mani Subramanian; Robert H Hyland; Sarah Arterburn; Deyuan Jiang; John McNally; Diana Brainard; William T Symonds; John G McHutchison; Aasim M Sheikh; Zobair Younossi; Edward J Gane
Journal:  N Engl J Med       Date:  2013-04-23       Impact factor: 91.245

6.  Hepatitis C in the general adult population of Oslo: prevalence and clinical spectrum.

Authors:  O Dalgard; S Jeansson; K Skaug; N Raknerud; H Bell
Journal:  Scand J Gastroenterol       Date:  2003-08       Impact factor: 2.423

7.  Characterisation of hepatitis C virus genotype among blood donors at the regional blood transfusion centre of Ouagadougou, Burkina Faso.

Authors:  Moctar Tokèda Abdoul Zeba; Mahamoudou Sanou; Cyrille Bisseye; Alice Kiba; Bolni Marius Nagalo; Florencia Wendkuuni Djigma; Tegwindé Rebecca Compaoré; Yacouba Koumpingnin Nebié; Kisito Kienou; Tani Sagna; Virginio Pietra; Rémy Moret; Jacques Simporé
Journal:  Blood Transfus       Date:  2014-01       Impact factor: 3.443

8.  The natural history of hepatitis C virus (HCV) infection.

Authors:  Stephen L Chen; Timothy R Morgan
Journal:  Int J Med Sci       Date:  2006-04-01       Impact factor: 3.738

9.  Antiviral therapy for prevention of hepatocellular carcinoma in chronic hepatitis C: systematic review and meta-analysis of randomised controlled trials.

Authors:  Nina Kimer; Emilie Kristine Dahl; Lise Lotte Gluud; Aleksander Krag
Journal:  BMJ Open       Date:  2012-10-22       Impact factor: 2.692

10.  Community-based HCV screening: knowledge and attitudes in a high risk urban population.

Authors:  Brianna L Norton; Corrine I Voils; Sarah H Timberlake; Emily J Hecker; Neela D Goswami; Kim M Huffman; Anneka Landgraf; Susanna Naggie; Jason E Stout
Journal:  BMC Infect Dis       Date:  2014-02-10       Impact factor: 3.090
View more
  32 in total

1.  Should we screen people at increased risk of hepatitis C virus infection?

Authors: 
Journal:  Can Fam Physician       Date:  2019-03       Impact factor: 3.275

2. 

Authors: 
Journal:  Can Fam Physician       Date:  2019-03       Impact factor: 3.275

3.  Identifying those infected with hepatitis C virus.

Authors:  Eric M Yoshida; Eberhard Renner; Philip Wong; Mel Krajden
Journal:  CMAJ       Date:  2017-06-26       Impact factor: 8.262

4.  Hepatitis C testing in Canada: don't leave baby boomers behind.

Authors:  Lianping Ti; Viviane Lima; Mark Hull; Bohdan Nosyk; Jeffrey Joy; Julio Montaner; Mel Krajden; Richard Harrigan; Thomas Kerr; Kate Shannon; Evan Wood; Jean Shoveller; Alnoor Ramji; Hin Hin Ko; Eric Yoshida; David Hall; Rolando Barrios
Journal:  CMAJ       Date:  2017-06-26       Impact factor: 8.262

5.  Expanding treatment for hepatitis C in Canada.

Authors:  James F Crismale; Jawad Ahmad
Journal:  CMAJ       Date:  2018-06-04       Impact factor: 8.262

6.  The management of chronic hepatitis C: 2018 guideline update from the Canadian Association for the Study of the Liver.

Authors:  Hemant Shah; Marc Bilodeau; Kelly W Burak; Curtis Cooper; Marina Klein; Alnoor Ramji; Dan Smyth; Jordan J Feld
Journal:  CMAJ       Date:  2018-06-04       Impact factor: 8.262

7.  Update to the Preventive Care Checklist Form©.

Authors:  Alina Zaltzman; Vinita Dubey; Karl Iglar
Journal:  Can Fam Physician       Date:  2020-04       Impact factor: 3.275

8.  Canadian hepatitis C virus screening guideline: a disconnect between evidence and recommendations.

Authors:  Alex Haines; William W L Wong; Murray Krahn
Journal:  CMAJ       Date:  2017-09-11       Impact factor: 8.262

9.  Quick and painless: 2018 Updates on guideline recommendations.

Authors:  Danielle O'Toole
Journal:  Can Fam Physician       Date:  2019-11       Impact factor: 3.275

10.  Model-based projection of health and economic effects of screening for hepatitis C in Canada.

Authors:  William W L Wong; Aysegul Erman; Jordan J Feld; Murray Krahn
Journal:  CMAJ Open       Date:  2017-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.